Member Info for ocelot

11am, but there has been no operations update RNS this morning, so today will be limited to the business of the AGM's resolutions.

no 7am RNS

MichaelGoodwill,

Why not ask the poster making such an allegation to provide the evidence to support it?

Filtered wealdpwr back in February, but have not yet filtered anyone else.

at 16:32:54

Nobody is going to the AGM!

The first drug proven to cut deaths from Covid-19 is not some new, expensive medicine but an old, cheap-as-chips steroid.

That is something to celebrate because it means patients across the world could benefit immediately. That's why the topline results of this trial have been rushed out because the implications are so huge globally.

Dexamethasone has been used since the early 1960s to treat a wide range of conditions, such as rheumatoid arthritis and asthma. Half of all Covid patients who require a ventilator do not survive, so cutting that risk by a third would have a huge impact...

record 17.7% rise in US retail sales last month, double the forecast (Bloomberg)

It was a "non-independent" piece of research, First Equity acting as broker to Alba.

It does mean, therefore, that Alba, UKOG's principal partner in HHDL, is unaware of anything untoward at HH.

Watching brief at present - tired of my inability to read it right!

The 1st 4 trades of 2x the same amounts all have the same time, so have probably been cancelled, leaving the one trade of 29m.

I suppose First Equity's report of yesterday provides potential buyers/joint venturers with a benchmark with which to work.

Not sure, trades 126 and 127 are currently missing from the sequence.

Sorry, think that was a late-reported trade from yesterday.

15m at 0.208p, better!

If they could get their share price up, it would actually help with the monetisation process: GF has made it clear he is not prepared to entertain buying interest on the basis of a percentage of the market cap, that serious buyers have to take account of the merits of the individual asset.

Nothing to stop them revising up their target as and when the share price approaches 0.56p.

10m at 0.2045p

Omitted the earliest peak around 0.60p, so there were 4 (not 3) of those.

Just looked at a 7-year graph: 3 peaks around 0.60p, 1 peak around 0.80p and 1 around 1.30p.

Even after the recent partial recovery, the current price is still in the lowest zone of the last 7 years.

The upside potential is there and substantial.